A benchmark for Monte Carlo simulations in gamma-ray spectrometry Part II: True coincidence summing correction factors.

The goal of this study is to provide a benchmark for the use of Monte Carlo simulation when applied to coincidence summing corrections. The examples are based on simple geometries: two types of germanium detectors and four kinds of sources, to mimic eight typical measurement conditions. The coincidence corrective factors are computed for four radionuclides. The exercise input files and calculation results with practical recommendations are made available for new users on a dedicated webpage.

Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study.

BACKGROUND: Bullous pemphigoid (BP), the by far most frequent autoimmune blistering skin disease (AIBD), is immunopathologically characterized by autoantibodies against the two hemidesmosomal proteins BP180 (collagen type XVII) and BP230 (BPAG1 or dystonin). Several comorbidities and potentially disease-inducing medication have been described in BP, yet a systematic analysis of these clinically relevant findings and autoantibody reactivities has not been performed. OBJECTIVE: To determine associations of autoantibody reactivities with comorbidities and concomitant medication. METHODS: In this prospective multicenter study, 499 patients diagnosed with BP in 16 European referral centers were included. The relation between anti-BP180 NC16A and anti-BP230 IgG ELISA values at the time of diagnosis as well as comorbidities and concomitant medication collected by a standardized form were analysed. RESULTS: An association between higher serum anti-BP180 reactivity and neuropsychiatric but not atopic and metabolic disorders was observed as well as with the use of insulin or antipsychotics but not with dipeptidyl peptidase-4 (DPP4) inhibitors, inhibitors of platelet aggregation and L-thyroxine. The use of DPP4 inhibitors was associated with less anti-BP180 and anti-BP230 reactivity compared with BP patients without these drugs. This finding was even more pronounced when compared with diabetic BP patients without DPP4 inhibitors. Associations between anti-BP180 and anti-BP230 reactivities were also found in patients using insulin and antipsychotics, respectively, compared with patients without this medication, but not for the use of inhibitors of platelet aggregation, and L-thyroxine. CONCLUSION: Taken together, these data imply a relation between autoantibody reactivities at the time of diagnosis and both neuropsychiatric comorbidities as well as distinct concomitant medication suggesting a link between the pathological immune mechanisms and clinical conditions that precede the clinically overt AIBD.

Decay data measurements on 213Bi using recoil atoms.

In this work, (213)Bi has been separated from an open (225)Ac source by collecting recoil atoms onto a glass plate in vacuum. The activity of such recoil sources has been measured as a function of time, using an ion-implanted planar Si detector in quasi-2π geometry. From these measurements, a new half-life value of T1/2((213)Bi)=45.62 (6)min was derived. Additionally, high-resolution alpha-spectrometry measurements were performed at a solid angle of 0.4% of 4πsr, to verify the energies and emission probabilities of the α-emissions from (213)Bi. Using (225)Ac, (221)Fr, (217)At and (213)Po peaks as reference peaks, the measured (213)Bi α-peak energies at Eα,0=5878 (4)keV and Eα,1=5560 (4)keV were about 10keV higher than validated data. The relative α-particle emission probabilities of (213)Bi, Pα,0=0.9155 (11) and Pα,1=0.0845 (11), and the (213)Bi alpha branching factor, Pα=1-Pß=2.140 (10)%, are compatible with recommended values, but have a higher accuracy.

Measurement of the 225Ac half-life.

The (225)Ac half-life was determined by measuring the activity of (225)Ac sources as a function of time, using various detection techniques: α-particle counting with a planar silicon detector at a defined small solid angle and in a nearly-2π geometry, 4πα+ß counting with a windowless CsI sandwich spectrometer and with a pressurised proportional counter, gamma-ray spectrometry with a HPGe detector and with a NaI(Tl) well detector. Depending on the technique, the decay was followed for 59-141 d, which is about 6-14 times the (225)Ac half-life. The six measurement results were in good mutual agreement and their mean value is T(1/2)((225)Ac)=9.920 (3)d. This half-life value is more precise and better documented than the currently recommended value of 10.0 d, based on two old measurements lacking uncertainty evaluations.

Results of an international comparison for the determination of radionuclide activity in bilberry material.

Radioactivity found in wild food products has assumed greater importance when assessing the total exposure of the population. For this reason, IRMM has been developing a reference material for the activity concentration of three radionuclides in bilberry samples. In order to characterise this new material, a CCRI(II) supplementary comparison was organised. The difficulties encountered in this comparison are discussed, in particular the efficiency calibration for volume sources of gamma-ray emitters, and comparison reference values for (137)Cs and (40)K are calculated.

Uranium enrichment measurements using the intensity ratios of self-fluorescence X-rays to 92* keV gamma ray in UXK alpha spectral region.

In this paper, the known multigroup gamma-ray analysis method for uranium (MGAU) as one of the non-destructive gamma-ray spectrometry methods has been applied to certified reference nuclear materials (depleted, natural and enriched uranium) containing (235)U isotope in the range of 0.32-4.51% atom (235)U. Its analysis gives incorrect results for the low component (235)U in depleted and natural uranium samples where the build-up of the decay products begins to interfere with the analysis. The results reveal that the build-up of decay products seems to be significant and thus the algorithms for the presence of decay products should be improved to resulting in the correct enrichment value. For instance, for the case of (235)U analysis in depleted uranium or natural ore samples, self-induced X-rays such as 94.6 keV and 98.4 keV lying in UXK(alpha) spectral region used by MGAU can be excluded from the calculation. Because the significant increases have been observed in the intensities of uranium self-induced X-rays due to gamma-ray emissions with above 100 keV energy arising from decay products of (238)U and (235)U and these parents. Instead, the use of calibration curve to be made between the intensity ratios of self-fluorescence X-rays to 92(*)keV gamma-ray and the certified (235)U abundances is suggested for the determination of (235)U when higher amounts of decay products are detected in the gamma-ray spectrum acquired for the MGAU analysis.